
1. Technology overview
Techcyte is a digital pathology company based in Orem, Utah, USA. It builds AI-powered digital diagnostics tools for anatomic pathology, clinical pathology, veterinary and environmental laboratories, aiming to reduce manual slide review.
Techcyte Fusion is presented as a unified anatomic and clinical digital pathology platform. Fusion AP covers histology and cytology workflows with DICOM support, a Fusion Partner Program for third-party AI models and LIS integrations, and scanner-agnostic slide ingestion. The SureView Cervical Cytology Solution runs on the same platform.
2. Highlighted features & specifications
- Fusion AP: anatomic pathology workflow for histology and cytology slides.
- Partner AI marketplace: integrations with Pramana, Aiosyn, Aiforia, Pictor Labs, Imagenomix and PathTools algorithms.
- LIS integration: NovoPath and Voquill LIS connections plus AI reporting.
- DICOM support: standards-based storage and exchange of whole slide images.
- SureView Cervical Cytology: AI-assisted cervical cytology review and quality control.
- Collaboration: Microsoft Teams meetings launched directly from Fusion AP.
3. Potential application
A large hospital pathology department in Vietnam can digitize histology slides and share cases with remote experts. A private diagnostic chain can run AI-assisted cervical cytology screening across branches. A university lab can combine education and research modules on one viewer.
4. Benefits
One platform for anatomic and clinical pathology reduces the number of separate systems a laboratory maintains. Third-party AI models and LIS integrations can be added without replacing the core viewer. Scanner-agnostic ingestion protects existing hardware investments. Per-slide bundles with Epredia scanners are offered through Fisher Healthcare.
5. Market trends & opportunities
Laboratories are moving from glass slides to digital workflows and want open platforms that accept several scanners and AI vendors. In Vietnam and Southeast Asia, large hospital laboratories and private pathology networks face pathologist shortages, which raises interest in AI-assisted screening and remote review.
6. Other information
Footer shows copyright 2014-2026 Techcyte, Inc., Orem, Utah. CE-IVDD marked in Europe; research use only in the US per the site. Founding year not stated on the fetched pages.
One platform connecting startups, corporations, research institutions, regions and investors











Playbook & Handbook · February 6, 2026
Winning Accelerator Playbook 2026 by BambuUP
EDTECH: LEVERAGING AI-POWERED TECHNOLOGIES TO TRANSFORM THE LEARNING EXPERIENCE








































